Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 913-922 , October 2008

The X in sex: how autoimmune diseases revolve around sex chromosomes

  • Carlo Selmi, MD, PhD (Assistant Professor)

      Affiliations

    • Corresponding Author InformationDepartment of Internal Medicine, University of Milan, IRCCS-Istituto Clinico Humanitas, Via Manzoni 113, 20089 Rozzano, Milan, Italy. Tel.: +39 02 5032 3088; Fax: +39 02 5032 3089.

References 

  1. Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark. Journal of Autoimmunity. 2007;29:1–9
  2. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology. 1997;84:223–243
  3. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell. 2007;130:25–35
  4. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. Journal of Autoimmunity. 2007;28:1–6
  5. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmunity Reviews. 2007;6:366–372
  6. Whitacre CC. Sex differences in autoimmune disease. Nature Immunology. 2001;2:777–780
  7. Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:5382–5386
  8. Medina KL, Garrett KP, Thompson LF, et al. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nature Immunology. 2001;2:718–724
  9. Grimaldi CM, Cleary J, Dagtas AS, et al. Estrogen alters thresholds for B cell apoptosis and activation. The Journal of Clinical Investigation. 2002;109:1625–1633
  10. Grimaldi CM, Jeganathan V, Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. Journal of Immunology. 2006;176:2703–2710
  11. Nalbandian G, Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunologic Research. 2005;31:91–106
  12. Edwards CJ, Cooper C. Early environmental exposure and the development of lupus. Lupus. 2006;15:814–819
  13. Lleo A, Selmi C, Invernizzi P, et al. The consequences of apoptosis in autoimmunity. Journal of Autoimmunity. 2008;[Epub ahead of print]
  14. Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001;21:225–232
  15. Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (Baltimore, Md.). 2005;42:1194–1202
  16. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. Journal of Autoimmunity. 2007;28:76–84
  17. Wakabayashi K, Lian ZX, Leung PS, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (Baltimore, Md.). 2008;48:531–540
  18. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet. 1998;351:559–562
  19. Murata H, Nakauchi H, Sumida T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet. 1999;354:220
  20. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA:The Journal of the American Medical Association. 2004;291:1127–1131
  21. Invernizzi P, Battezzati PM, Podda M, et al. Presence of fetal DNA in maternal plasma decades after pregnancy: further comments. Human Genetics. 2002;111:576
  22. Ellegren H, Hultin-Rosenberg L, Brunstrom B, et al. Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes. BMC Biology. 2007;5:40
  23. Sharp A, Robinson D, Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Human Genetics. 2000;107:343–349
  24. Chagnon P, Provost S, Belisle C, et al. Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Experimental Hematology. 2005;33:1209–1214
  25. Brown CJ, Robinson WP. The causes and consequences of random and non-random X chromosome inactivation in humans. Clinical Genetics. 2000;58:353–363
  26. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science. 2007;315:1141–1143
  27. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–404
  28. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. The Journal of Pediatrics. 1982;100:731–737
  29. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147–157
  30. Gulino AV, Notarangelo LD. Hyper IgM syndromes. Current Opinion in Rheumatology. 2003;15:422–429
  31. Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Current Opinion in Rheumatology. 2003;15:446–453
  32. Ranke MB, Saenger P. Turner's syndrome. Lancet. 2001;358:309–314
  33. Davis CJ, Davison RM, Payne NN, et al. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Human Reproduction. 2000;15:2418–2422
  34. Milkiewicz P, Heathcote J. Can Turner syndrome teach us about the pathogenesis of chronic cholestasis?. Hepatology (Baltimore, Md.). 2004;40:1226–1228
  35. Huang Q, Parfitt A, Grennan DM, et al. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity. 1997;26:85–93
  36. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunology Today. 1998;19:352–357
  37. Chitnis S, Monteiro J, Glass D, et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Research. 2000;2:399–406
  38. Knudsen GP, Harbo HF, Smestad C, et al. X chromosome inactivation in females with multiple sclerosis. European Journal of Neurology. 2007;14:1392–1396
  39. Lu Q, Wu A, Tesmer L, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. Journal of Immunology. 2007;179:6352–6358
  40. Desai-Mehta A, Lu L, Ramsey-Goldman R, et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. The Journal of Clinical Investigation. 1996;97:2063–2073
  41. Cornacchia E, Golbus J, Maybaum J, et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. Journal of Immunology. 1988;140:2197–2200
  42. Richardson B, Scheinbart L, Strahler J, et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis and Rheumatism. 1990;33:1665–1673
  43. Richardson B. Primer: epigenetics of autoimmunity. Nature Clinical Practice. Rheumatology. 2007;3:521–527
  44. Ozbalkan Z, Bagislar S, Kiraz S, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis and Rheumatism. 2005;52:1564–1570
  45. Uz E, Loubiere LS, Gadi VK, et al. Skewed X-Chromosome inactivation in Scleroderma. Clinical Reviews in Allergy & Immunology. 2007;34:352–355
  46. Brix TH, Knudsen GP, Kristiansen M, et al. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. The Journal of clinical endocrinology and metabolism. 2005;90:5949–5953
  47. Ozcelik T, Uz E, Akyerli CB, et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. European Journal of Human Genetics. 2006;14:791–797
  48. Yin X, Latif R, Tomer Y, et al. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Annals of the New York Academy of Sciences. 2007;1110:193–200
  49. Ozcelik T. X Chromosome inactivation and female predisposition to autoimmunity. Clinical Reviews in Allergy & Immunology. 2008;34:348–351
  50. Miozzo M, Selmi C, Gentilin B, et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology (Baltimore, Md.). 2007;46:456–462
  51. Invernizzi P, Miozzo M, Battezzati PM, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet. 2004;363:533–535
  52. Invernizzi P, Miozzo M, Selmi C, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. Journal of Immunology. 2005;175:575–578
  53. Invernizzi P, Miozzo M, Oertelt-Prigione S, et al. X monosomy in female systemic lupus erythematosus. Annals of the New York Academy of Sciences. 2007;1110:84–91
  54. Selmi C, Invernizzi P, Miozzo M, et al. Primary biliary cirrhosis: does X mark the spot?. Autoimmunity Reviews. 2004;3:493–499
  55. Selmi C, Invernizzi P, Gershwin ME. The X chromosome and systemic sclerosis. Current Opinion in Rheumatology. 2006;18:601–605
  56. Lang KS, Burow A, Kurrer M, et al. The role of the innate immune response in autoimmune disease. Journal of Autoimmunity. 2007;29:206–212
  57. Jordan MA, Baxter AG. The genetics of immunoregulatory T cells. Journal of Autoimmunity. 2008;
  58. Abbas AK, Lohr J, Knoechel B. Balancing autoaggressive and protective T cell responses. Journal of Autoimmunity. 2007;28:59–61[Epub ahead of print]
  59. Youinou P. B cell conducts the lymphocyte orchestra. Journal of Autoimmunity. 2007;28:143–151
  60. Hamerton JL, Canning N, Ray M, et al. A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clinical Genetics. 1975;8:223–243
  61. Dubois EL, Kaplan BJ. Letter: S.L.E. and Klinefelter's syndrome. Lancet. 1976;1:93
  62. Price WH, MacLean N, Littlewood AP. Letter: S.L.E. and Klinefelter's syndrome. Lancet. 1976;1:807
  63. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis and Rheumatism. 2008;58:2511–2517
  64. Murphy ED, Roths Jb. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis and Rheumatism. 1979;22:1188–1194
  65. Merino R, Fossati L, Lacour M, et al. Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa- bone marrow chimeric mice. The Journal of Experimental Medicine. 1991;174:1023–1029
  66. Subramanian S, Tus K, Li QZ, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:9970–9975
  67. Fairhurst AM, Hwang SH, Wang A, et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. European Journal of Immunology. 2008;38:1971–1978
  68. Santiago-Raber ML, Kikuchi S, Borel P, et al. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. Journal of Immunology. 2008;181:1556–1562
  69. Berghofer B, Frommer T, Haley G, et al. TLR7 ligands induce higher IFN-alpha production in females. Journal of Immunology. 2006;177:2088–2096
  70. Gorden KK, Qiu XX, Binsfeld CC, et al. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. Journal of Immunology. 2006;177:6584–6587
  71. Lleo A, Battezzati PM, Selmi C, et al. Is autoimmunity a matter of sex?. Autoimmunity Reviews. 2008;7:626–630
  72. Arber S, McKinlay J, Adams A, et al. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Social Science & Medicine. 2006;62:103–115

PII: S1521-6942(08)00099-5

doi: 10.1016/j.berh.2008.09.002

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 913-922 , October 2008

Article Tools